The gastrin-releasing peptide receptor as a marker of dysplastic alterations in cervical epithelial cells

Oncology
Daniela Baumann CornelioRafael Roesler

Abstract

Cervical cancer is a leading cancer in women worldwide. The Papanicolaou test (Pap test) remains the main screening tool; however, it produces high rates of false-negative and false-positive results. Gastrin-releasing peptide is a growth factor that has been implicated in many cancers, and its main receptor, the gastrin-releasing peptide receptor (GRPR), is nearly always expressed in cervical dysplasias and invasive carcinomas. The aim of this study was to evaluate the diagnostic potential of GRPR immunocytochemistry in detecting cervical dysplasia and invasive cancer. Cervical smears were collected from 66 women in Brazil and subjected to GRPR immunocytochemistry and the Pap test. GRPR and p16 immunohistochemistry were performed in biopsies if abnormalities were detected. GRPR immunostaining sensitivity in detecting cervical lesions was 87.5% and its specificity was 76.7%. GRPR immunostaining showed 80% accuracy in identifying atypical squamous cells of undetermined significance (ASCUS), with 88% sensitivity and 71% specificity. This is the first immunocytochemical evaluation of GRPR expression in cervical epithelial cells. This biomarker was strongly associated with cervical dysplasia and invasive cancers. GRPR immunosignalin...Continue Reading

References

Jul 1, 1995·Annals of Surgery·K U ChuJ C Thompson
Apr 22, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J C SaurinJ A Chayvialle
May 11, 1999·JAMA : the Journal of the American Medical Association·M M ManosR A Hiatt
Aug 14, 1999·The Journal of Biological Chemistry·M R HellmichC M Townsend
Mar 23, 2001·JAMA : the Journal of the American Medical Association·M H StolerUNKNOWN Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·R KlaesM von Knebel Doeberitz
Mar 7, 2002·Journal of the National Cancer Institute·Miriam N LangoJennifer Rubin Grandis
May 1, 2002·Annals of Surgery·Sunghoon KimDai H Chung
Jun 26, 2003·American Journal of Obstetrics and Gynecology·UNKNOWN ASCUS-LSIL Traige Study (ALTS) Group
Jun 26, 2003·American Journal of Obstetrics and Gynecology·UNKNOWN ASCUS-LSIL Traige Study (ALTS) Group
May 11, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A Sharma, U Menon
Jun 17, 2006·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Suki KangNam Hoon Cho
Jul 22, 2006·Advances in Anatomic Pathology·Alexandra N Kalof, Kumarasen Cooper
Mar 14, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D B CornelioG Schwartsmann
Oct 19, 2007·The New England Journal of Medicine·Pontus NauclerJoakim Dillner
Jan 1, 2008·Obstetrics and Gynecology·Marc ArbynJohan Bulten
May 24, 2008·Oncology·Daniela Baumann CornelioGilberto Schwartsmann
Mar 10, 2010·Brain Research Bulletin·Debora Gazzana FloresRafael Roesler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.